AHEAD Study Investigator Meeting

AHEAD Study Investigator Meeting

On behalf of Shire, we are delighted to formally invite you to the upcoming AHEAD Study Investigators’ Meeting which will be held in Berlin, just before the ISTH Congress. The objectives of this meeting are to share data of most recent interim analysis, to discuss future analyses, data dissemination and publication plans and to introduce the new study amendment, that allows follow-up and inclusion of patients treated with ADYNOVATE/BAX 855.

  

Meeting date: Saturday, July 8th 2017, from 1.30 to 4.30pm CEDT

Meeting location: Hilton Berlin, Mohrenstrasse 30, 10117 Berlin, Germany

 

More information will be provided to you in due course. 

 

YES, I confirm my participation

NO, I’m unable to attend this Investigator Meeting

 

Please don’t hesitate to contact us for any questions you might have. 

 

Alessandro Gringeri, MD, MSc

AHEAD Study Medical Director

Global Medical Affairs - Hematology

Shire

Tel: +43 (0) 1 20100 247 6226

alessandro.gringeri@shire.com

Katharina Steinitz-Trost, PhD

AHEAD Study Project Lead

Global Medical Affairs - Hematology

Shire

Tel: +43 (0)1 20100 247 6034

katharina.steinitz@shire.com

 

 

Contact

Avenue des Courses 20 1050 Bruxelles
info@destination.be
T +32 2 626 09 50
Because you mean the world to us #incentive #congress #executivetraining #venuefinding
Privacy
Disclaimer
Sitemap

Webdesign by

Abonnez-vous à notre newsletter

{{ newsletter_message }}

x